Comparison of the use of Solidago chilensis (Arnica) and low-level laser therapy for the prevention of oral mucositis in patients submitted of head and neck radiotherapy and/or high toxicity chemotherapy
DOI:
https://doi.org/10.33448/rsd-v10i14.22128Keywords:
Arnica; Laser Therapy; Oral Mucositis; Solidago chilensis; Solidago microglossus.Abstract
The oral mucositis is an adverse event of radiotherapy and/or high toxicity chemotherapy. The Solidago chilensis (Arnica) has been used for its antiseptic, analgesic, healing and anti-inflammatory properties. Objective: The purpose of this study was to evaluate the uses of Arnica for oral mucositis prevention in patients submitted to radiotherapy for head and neck tumors treatment and/or high toxicity chemotherapy. Methodology: The determination of the cytotoxicity index of the aqueous extract was determined in vitro. The oral mucosa was evaluated in days 0, 10 and 14 of patients in the groups: treated with lasertherapy (L, n=18), treated with Arnica (A, n=24) and, treated with lasertherapy associated with Arnica (LA, n=4). It was considered significant p<0.05. Results: It was determined IC50=90,74 μg/mL of Arnica’s aqueous extract in SCC-4 cells. The development of oral mucositis was associated with the type of treatment for oral mucositis prevention: L, A, and LA (χ2 = 24,72, p<0.0001). The level of oral mucositis had significant interaction with the type of prevention treatment [F(2) = 9.545, p<0.0001] and, within 14 days [F(2) = 11.995, p<0.0001]. Conclusions: The results obtained suggest which the use of Solidago chilensis (Arnica) can be an important therapeutic option for treatment with low-level laser therapy for oral mucositis prevention in patients submitted of head and neck radiotherapy and/or high toxicity chemotherapy.
References
Anderson, H., Hopwood, P., Prendiville, J., Radford, J. A., Thatcher, N., & Ashcroft, L. (1993). A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer. British Journal of Cancer, 67(6). https://doi.org/10.1038/bjc.1993.256
Baharvand, M., Jafari, S., & Mortazavi, H. (2017). Herbs in oral mucositis. In Journal of Clinical and Diagnostic Research (Vol. 11, Issue 3). https://doi.org/10.7860/JCDR/2017/21703.9467
Bano, N., Najam, R., Qazi, F., & Mateen, A. (2014). Gastrointestinal adverse effects in advanced colorectal carcinoma patients treated with different schedules of FOLFOX. Asian Pacific Journal of Cancer Prevention, 15(19). https://doi.org/10.7314/APJCP.2014.15.19.8089
Barasch, A., & Peterson, D. E. (2003). Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. In Oral Oncology (Vol. 39, Issue 2). https://doi.org/10.1016/S1368-8375(02)00033-7
Barkokebas, A., Silva, I. H. M., de Andrade, S. C., Carvalho, A. A. T., Gueiros, L. A. M., Paiva, S. M., & Leão, J. C. (2015). Impact of oral mucositis on oral-health-related quality of life of patients diagnosed with cancer. Journal of Oral Pathology and Medicine, 44(9). https://doi.org/10.1111/jop.12282
Bensadoun, R. J., Franquin, J. C., Ciais, G., Darcourt, V., Schubert, M. M., Viot, M., Dejou, J., Tardieu, C., Benezery, K., Nguyen, T. D., Laudoyer, Y., Dassonville, O., Poissonnet, G., Vallicioni, J., Thyss, A., Hamdi, M., Chauvel, P., & Demard, F. (1999). Low-energy He/Ne laser in the prevention of radiation-induced mucositis: A multicenter phase III randomized study in patients with head and neck cancer. Supportive Care in Cancer, 7(4). https://doi.org/10.1007/s005200050256
Bishop, J., Lowenthal, R., Joshua, D., Matthews, J., Todd, D., Cobcroft, R., Whiteside, M., Kronenberg, H., Ma, D., & Dodds, A. (1990). Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood, 75(1). https://doi.org/10.1182/blood.v75.1.27.bloodjournal75127
Borenfreund, E., Babich, H., & Martin-Alguacil, N. (1988). Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests. Toxicology in Vitro, 2(1). https://doi.org/10.1016/0887-2333(88)90030-6
Borenfreund, E., & Puerner, J. A. (1985). Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicology Letters, 24(2–3). https://doi.org/10.1016/0378-4274(85)90046-3
Bowen, J. M., & Wardill, H. R. (2017). Advances in the understanding and management of mucositis during stem cell transplantation. In Current Opinion in Supportive and Palliative Care (Vol. 11, Issue 4). https://doi.org/10.1097/SPC.0000000000000310
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6). https://doi.org/10.3322/caac.21492
Cowen, D., Tardieu, C., Schubert, M., Peterson, D., Resbeut, M., Faucher, C., & Franquin, J. C. (1997). Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: Results of a double blind randomized trial. International Journal of Radiation Oncology Biology Physics, 38(4). https://doi.org/10.1016/S0360-3016(97)00076-X
Eduardo, F. E. P., et al. The influence of dental care associated with laser therapy on oral mucositis during allogeneic hematopoietic cell transplant: retrospective study. Einstein (Sao Paulo), v. 9, n. 2, p. 201-6, Jun 2011.
Epstein, J. B., & Schubert, M. M. (1999). Oral mucositis in myelosuppressive cancer therapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 88(3). https://doi.org/10.1016/s1079-2104(99)70026-0
Ernst, E. (2003). The benefits of Arnica: 16 Case reports. Homeopathy, 92(4). https://doi.org/10.1016/j.homp.2003.07.001
Gautam, A. P., Fernandes, D. J., Vidyasagar, M. S., Maiya, A. G., & Vadhiraja, B. M. (2012). Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - A triple blinded randomized controlled trial. Radiotherapy and Oncology, 104(3). https://doi.org/10.1016/j.radonc.2012.06.011
Goulart, S., Moritz, M. I. G., Lang, K. L., Liz, R., Schenkel, E. P., & Fröde, T. S. (2007). Anti-inflammatory evaluation of Solidago chilensis Meyen in a murine model of pleurisy. Journal of Ethnopharmacology, 113(2). https://doi.org/10.1016/j.jep.2007.07.003
Huber, M. A., & Terezhalmy, G. T. (2005). The medical oncology patient. Quintessence International (Berlin, Germany : 1985), 36(5), 383–402. http://www.ncbi.nlm.nih.gov/pubmed/15892536
Katranci, N., Ovayolu, N., Ovayolu, O., & Sevinc, A. (2012). Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy - A randomized controlled trial. European Journal of Oncology Nursing, 16(4). https://doi.org/10.1016/j.ejon.2011.07.008
Kostler, W. J., Hejna, M., Wenzel, C., & Zielinski, C. C. (2001). Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment. CA: A Cancer Journal for Clinicians, 51(5). https://doi.org/10.3322/canjclin.51.5.290
Lacayo, N. J., Lum, B. L., Becton, D. L., Weinstein, H., Ravindranath, Y., Chang, M. N., Bomgaars, L., Lauer, S. J., Sikic, B. I., & Dahl, G. V. (2002). Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. Leukemia, 16(5). https://doi.org/10.1038/sj.leu.2402455
Lins, R. D. A. U., Dantas, E. M., Lucena, K. C. R., Catão, M. H. C. V., Granville-Garcia, A. F., & Carvalho Neto, L. G. (2010). Biostimulation effects of low-power laser in the repair process. In Anais Brasileiros de Dermatologia (Vol. 85, Issue 6). https://doi.org/10.1590/S0365-05962010000600011
Mallick, S., Benson, R., & Rath, G. K. (2016). Radiation induced oral mucositis: a review of current literature on prevention and management. In European Archives of Oto-Rhino-Laryngology (Vol. 273, Issue 9). https://doi.org/10.1007/s00405-015-3694-6
Malpezzi-Marinho, E. L. A., Molska, G. R., Freire, L. I. G. P., Silva, C. I., Tamura, E. K., Berro, L. F., Parada, C. A., & Marinho, E. A. V. (2019). Effects of hydroalcoholic extract of Solidago chilensis Meyen on nociception and hypernociception in rodents. BMC Complementary and Alternative Medicine, 19(1). https://doi.org/10.1186/s12906-019-2478-8
Martins, M. D., Marques, M. M., Bussadori, S. K., Mesquita-Ferrari, R. A., Pavesi, V. C. S., Wadt, N. S., & Fernandes, K. P. (2009). Citotoxicidade in vitro de extratos de arnica brasileira (Solidago microglossa) e arnica paulista (Porophyllum ruderale). ConScientiae Saúde, 8(1). https://doi.org/10.5585/conssaude.v8i1.1457
Meyer-Hamme, G., Beckmann, K., Radtke, J., Efferth, T., Greten, H. J., Rostock, M., & Schröder, S. (2013). A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. In Evidence-based Complementary and Alternative Medicine (Vol. 2013). https://doi.org/10.1155/2013/284959
National Cancer Institute. (2009). Common Terminology Criteria for Adverse Events ( CTCAE ) version 4.0. NIH Publication.
Neubig, R. R., Spedding, M., Kenakin, T., & Christopoulos, A. (2003). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. In Pharmacological Reviews (Vol. 55, Issue 4). https://doi.org/10.1124/pr.55.4.4
Öhrn, K. E., Wahlin, Y. B., & Sjödén, P. O. (2001). Oral status during radiotherapy and chemotherapy: A descriptive study of patient experiences and the occurrence of oral complications. Supportive Care in Cancer, 9(4). https://doi.org/10.1007/s005200000214
Pereira, A. S., et al. (2018). Metodologia da pesquisa cientifica. [free e-book]. Santa Maria: UAB/NTE/UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1.
Porock, D. (2002). Factors influencing the severity of radiation skin and oral mucosal reactions: Development of a conceptual framework. European Journal of Cancer Care, 11(1). https://doi.org/10.1046/j.1365-2354.2002.00287.x
Rady, I., Bloch, M. B., Chamcheu, R. C. N., Banang Mbeumi, S., Anwar, M. R., Mohamed, H., Babatunde, A. S., Kuiate, J. R., Noubissi, F. K., El Sayed, K. A., Whitfield, G. K., & Chamcheu, J. C. (2018). Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. Oxidative Medicine and Cellular Longevity, 2018. https://doi.org/10.1155/2018/1826170
Redding, S. W. (2005). Cancer Therapy-Related Oral Mucositis. Journal of Dental Education, 69(8). https://doi.org/10.1002/j.0022-0337.2005.69.8.tb03989.x
Rose-Ped, A. M., Bellm, L. A., Epstein, J. B., Trotti, A., Gwede, C., & Fuchs, H. J. (2002). Complications of radiation therapy for head and neck cancers: The patient’s perspective. Cancer Nursing, 25(6). https://doi.org/10.1097/00002820-200212000-00010
Saini, A., Norman, A. R., Cunningham, D., Chau, I., Hill, M., Tait, D., Hickish, T., Iveson, T., Lofts, F., Jodrell, D., Ross, P. J., & Oates, J. (2003). Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. British Journal of Cancer, 88(12). https://doi.org/10.1038/sj.bjc.6600995
Santos, R. L., Guimaraes, G. P., Nobre, M. S. C., & Portela, A. S. (2011). Analysis about phytotherapy as an integrating practice in the Brazilian Unified Health System (Uhs). In Revista Brasileira de Plantas Medicinais (Vol. 13, Issue 4). https://doi.org/10.1590/s1516-05722011000400014
Scully, C., Sonis, S., & Diz, P. (2006). Oral mucositis. Oral Diseases, 12(3), 229–241. https://doi.org/10.1111/j.1601-0825.2006.01258.x
Shin, H. J., Joo, S. C., Lee, J. J., Sang, K. S., Young, J. C., Kim, Y. K., Yang, D. H., Kim, H. J., Jong, G. K., Young, D. J., Won, S. L., Sohn, C. H., Eun, Y. L., & Goon, J. C. (2008). Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. Journal of Korean Medical Science, 23(3). https://doi.org/10.3346/jkms.2008.23.3.439
Sonis, S. T. (1998). Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology, 34(1). https://doi.org/10.1016/S1368-8375(97)00053-5
Sonis, Stephen T. (2007). Pathobiology of oral mucositis: Novel insights and opportunities. In Journal of Supportive Oncology (Vol. 5, Issue 9 SUPPL. 4).
Sonis, S. T. (2009). Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. In Oral Oncology (Vol. 45, Issue 12). https://doi.org/10.1016/j.oraloncology.2009.08.006
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., & Rubenstein, E. B. (2004). Perspectives on Cancer Therapy-Induced Mucosal Injury: Pathogenesis, Measurement, Epidemiology, and Consequences for Patients. In Cancer (Vol. 100, Issue 9 SUPPL.). https://doi.org/10.1002/cncr.20162
Sung, J. H., Lee, J. O., Son, J. K., Park, N. S., Kim, M. R., Kim, J. G., & Moon, D. C. (1999). Cytotoxic constituents from Solidago virga-aurea var. gigantea MIQ. Archives of Pharmacal Research, 22(6). https://doi.org/10.1007/BF02975338
Suresh, A. V. S., Varma, P. P., Sinha, S., Deepika, S., Raman, R., Srinivasan, M., Mandapal, T., Reddy, C. O., & Anand, B. B. (2010). Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]. Journal of Cancer Research and Therapeutics, 6(4). https://doi.org/10.4103/0973-1482.77100
Treister, N., & Sonis, S. (2007). Mucositis: Biology and management. In Current Opinion in Otolaryngology and Head and Neck Surgery (Vol. 15, Issue 2). https://doi.org/10.1097/MOO.0b013e3280523ad6
Triglia, D., Braa, S. S., Yonan, C., & Naughton, G. K. (1991). In vitro toxicity of various classes of test agents using the neutral red assay on a human three-dimensional physiologic skin model. In Vitro Cellular & Developmental Biology - Animal, 27(3). https://doi.org/10.1007/BF02630923
Valverde-Soares, S. S., Oliveira, T. B., & Souza, S. P. (2012). Solidago chilensis Meyen (Asteraceae). Revista Fitos, 7(3).
Valverde, S. S., Santos, B. C. S., de Oliveira, T. B., Gonçalves, G. C., & de Sousa, O. V. (2021). Solidagenone from Solidago chilensis Meyen inhibits skin inflammation in experimental models. Basic and Clinical Pharmacology and Toxicology, 128(1). https://doi.org/10.1111/bcpt.13479
Vokurka, S., Bystrická, E., Koza, V., Scudlová, J., Pavlicová, V., Valentová, D., Visokaiová, M., & Misaniová, L. (2006). Higher incidence of chemotherapy induced oral mucositis in females: A supplement of multivariate analysis to a randomized multicentre study. Supportive Care in Cancer, 14(9). https://doi.org/10.1007/s00520-006-0031-z
Wang, H. M., Hsu, C. L., Hsieh, C. H., Fan, K. H., Lin, C. Y., Chang, J., Huang, S. F., Chen, I. H., Liao, C. T., & Ng, S. K. (2014). Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx. Biomedical Journal, 37(3). https://doi.org/10.4103/2319-4170.117893
Wilkes, J. D. (1998). Prevention and treatment of oral mucositis following cancer chemotherapy. In Seminars in Oncology (Vol. 25, Issue 5).
Yarom, N., Ariyawardana, A., Hovan, A., Barasch, A., Jarvis, V., Jensen, S. B., Zadik, Y., Elad, S., Bowen, J., & Lalla, R. V. (2013). Systematic review of natural agents for the management of oral mucositis in cancer patients. In Supportive Care in Cancer (Vol. 21, Issue 11). https://doi.org/10.1007/s00520-013-1869-5
Zadik, Y., Arany, P. R., Fregnani, E. R., Bossi, P., Antunes, H. S., Bensadoun, R. J., Gueiros, L. A., Majorana, A., Nair, R. G., Ranna, V., Tissing, W. J. E., Vaddi, A., Lubart, R., Migliorati, C. A., Lalla, R. V., Cheng, K. K. F., & Elad, S. (2019). Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 27(10). https://doi.org/10.1007/s00520-019-04890-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ana Cristina Lopes; Giovana Ferreira Gonçalves; Anna Cecília Dias Maciel Carneiro; André Luiz Pantoja dos Santos; Frederico Nobrega Tomas; Leonardo Rodrigues de Oliveira; Karina Ferrazzoli Devienne; Virginia Oliveira Crema
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
